Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
338 studies found for:    "Nasopharyngeal Neoplasms"
Show Display Options
Rank Status Study
1 Completed Study of Alimta in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC) Who Have Had Prior Platinum Based Chemotherapy
Condition: Nasopharyngeal Neoplasms
Intervention: Drug: Pemetrexed (Alimta)
2 Completed Study of Combination of Sorafenib With Cisplatin and 5-fluorouracil as First-line Treatment of Recurrence After Radiotherapy Patients Who Failed With Radiotherapy in Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC)
Condition: Nasopharyngeal Neoplasms
Intervention: Drug: Sorafenib plus Cisplatin and 5-fluorouracil
3 Not yet recruiting Measuring Patient-Reported Adverse Events in Oncology Practice Improves Quality of Life in Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Neoplasms
Interventions: Other: adverse events using patient-reported outcomes version of common terminology criteria for adverse events (PRO-CTCAE) questionaire;   Other: do not report adverse events through patient-reported outcomes version of common terminology criteria for adverse events (PRO-CTCAE) questionaire
4 Recruiting A Trial of Endostar in Patients With Carcinoma of the Head and Neck
Condition: Nasopharyngeal Neoplasms
Intervention: Drug: Endostar
5 Recruiting Study of Pembrolizumab (MK-3475) in Platinum Pre-treated Recurrent/Metastatic Nasopharyngeal Cancer (MK-3475-122, KEYNOTE-122)
Condition: Nasopharyngeal Neoplasms
Interventions: Biological: Pembrolizumab;   Drug: Capecitabine;   Drug: Gemcitabine;   Drug: Docetaxel
6 Enrolling by invitation A Trial of Endostar in Combination With Chemotherapy of DF and Sequential Intensity Modulated Radiation Therapy for Patients With Advanced Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Neoplasms
Interventions: Drug: endostar;   Radiation: intensity modulated radiation;   Drug: cisplatin
7 Completed The Role of Induction Chemotherapy for High-risk Locally Advanced Nasopharyngeal Carcinoma in the Era of IMRT
Condition: Nasopharyngeal Neoplasms
Interventions: Drug: Cisplatin;   Drug: Paclitaxel;   Radiation: IMRT
8 Unknown  Benefit of Changing Chemoradiotherapy Sequence and Modifying Radiotherapy Schedule for Advanced Nasopharyngeal Cancer
Condition: Nasopharyngeal Neoplasms
Interventions: Procedure: Conventional Radiotherapy;   Procedure: Accelerated Radiotherapy;   Drug: Cisplatin;   Drug: 5-fluorouracil;   Drug: Capecitabine
9 Completed Gemcitabine and Oxaliplatin (GEMOX) in First Line Metastatic or Recurrent Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Neoplasms
Interventions: Drug: Gemcitabine;   Drug: Oxaliplatin
10 Completed Taxotere + Cisplatin in Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Neoplasms
Interventions: Drug: Docetaxel;   Drug: Cisplatin
11 Unknown  Combination of Capecitabine and Oxaliplatin in Metastatic Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Neoplasms
Intervention: Drug: Oxaliplatin
12 Active, not recruiting Intensity Modulated Radiation Therapy for Head and Neck Cancer
Condition: Nasopharyngeal Neoplasms
Interventions: Procedure: intensity modulated radiation therapy;   Drug: cisplatinium and fluorouracil - standard treatment
13 Completed Study Using Intensity-modulated Radiation Therapy in Patients With Nasopharynx Cancer to Permit Sparing of Contralateral Parotid Gland Function
Condition: Nasopharyngeal Neoplasms
Intervention: Procedure: Intensity-modulated radiation therapy
14 Recruiting A New EBV Related Technologies of T Cells in Treating Malignant Tumors and Clinical Application
Condition: Nasopharyngeal Neoplasms
Intervention: Other: CAR-T cells
15 Recruiting ADjuVant Apatinib in Nasopharyngeal Carcinoma Patients With Residual Epstein-Barr Virus (EBV) DNA Following Radiotherapy
Condition: Nasopharyngeal Neoplasms
Interventions: Drug: Apatinib;   Drug: Placebo
16 Recruiting Clinical Target Volume Based on Disease Extension Risk Atlas and Computer-aided Delineation in Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Neoplasms
Interventions: Radiation: IMRT using individualized CTV;   Radiation: IMRT using traditional CTV;   Drug: Gemcitabine and cisplatin (induction chemotherapy);   Drug: Docetaxel and cisplatin (induction chemotherapy);   Drug: Cisplatin 100mg/m² concurrent chemotherapy;   Drug: Cisplatin 80mg/m² concurrent chemotherapy
17 Completed The Value of Diagnosis and Outcome Prediction in CTC for Metastatic NPC Patients
Condition: Nasopharyngeal Neoplasms
Intervention: Other: the number of circulating tumor cells
18 Completed Combination of Docetaxel, Cisplatin, and Capecitabine (DCX) in the Treatment of Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Neoplasms
Interventions: Drug: Docetaxel;   Drug: Cisplatin;   Drug: Capecitabine
19 Active, not recruiting Safety and Efficacy of Oral Azacitidine in Previously Treated Subjects With Locally Advanced or Metastatic Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Neoplasms
Intervention: Drug: CC-486
20 Recruiting Efficacy and Safety of TC+AVASTIN Versus TC in Patients With Metastatic Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Neoplasms
Interventions: Drug: Paclitaxel;   Drug: Bevacizumab;   Drug: Carboplatin

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.